Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience

OBJECTIVES: To evaluate the proportion of patients who have successfully withdrawn glucocorticoids (GCs) in a longitudinal cohort of patients with systemic lupus erythematosus (SLE) over a period of 6 years; to evaluate patient characteristics during GC withdrawal in relation to existing definitions...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Chiara, Elefante, Elena, Signorini, Viola, Zucchi, Dina, Lorenzoni, Valentina, Carli, Linda, Stagnaro, Chiara, Ferro, Francesco, Mosca, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Lupus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579574/
https://www.ncbi.nlm.nih.gov/pubmed/31275608
http://dx.doi.org/10.1136/rmdopen-2019-000916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579574/
https://www.ncbi.nlm.nih.gov/pubmed/31275608
http://dx.doi.org/10.1136/rmdopen-2019-000916

Ejemplares similares